Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment
Zhang J, Späth SS, Marjani SL, Zhang W, Pan X. Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment. Precision Clinical Medicine 2018, 1: 29-48. PMID: 30687561, PMCID: PMC6333046, DOI: 10.1093/pcmedi/pby007.Peer-Reviewed Original ResearchNew next-generation sequencing technologiesGenomic heterogeneityNext-generation sequencing technologiesLarge-scale genomic studiesDiverse cell populationsGenomic studiesKey genesNext-generation sequencingSequencing technologiesSpecific molecular biomarkersGenomic alterationsNew therapeutic discoveriesGenomicsTherapeutic discoveryUnique genomicsCell populationsTumor developmentTCGA databaseMolecular heterogeneityPhenotypic featuresMolecular biomarkersMost common cancersPrecision medicineTumor heterogeneityTumor genomics
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply